| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | 3 | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | — | — | — | — | — | 1 | — | 1 | — | 1 |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.40 |
—
—
—
—
|
| 2025 | 0.40 |
—
—
—
—
|
| 2024 | 0.30 |
—
—
—
|
| 2023 | 0.40 |
—
—
—
—
|
| 2022 | 0.40 |
—
—
—
—
|
| 2021 | 0.40 |
—
—
—
—
|
| 2020 | 0.40 |
—
—
—
—
|
| 2019 | 0.40 |
—
—
—
—
|
| 2018 | 0.32 |
—
—
—
—
|
| 2017 | 0.24 |
—
—
—
—
|
| 2016 | 0.24 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 179.00 | 152.10 | 206.30 | 158.50 |
| Receivables | 230.80 | 209.40 | 162.10 | 221.10 |
| Inventory | 373.60 | 247.80 | 274.20 | 269.30 |
| Other | 160.60 | 86.40 | 86.80 | 87.30 |
| 1,025.10 | 695.70 | 729.40 | 736.20 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 206.00 | 200.90 | 174.70 | 189.70 |
| ST’ Debt | 10.00 | 10.00 | — | — |
| Other | 24.20 | — | — | — |
| 869.40 | 533.10 | 521.10 | 475.20 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 457.60 | 506.40 | — | — |
—
|
| ’25 | 412.30 | 474.20 | 470.30 | 517.50 |
1,874.30
|
| ’24 | 394.90 | 425.20 | 440.20 | 494.70 |
1,755.00
|
| ’23 | 599.40 | 589.10 | 527.70 | 526.70 |
2,242.90
|
| ’22 | 614.80 | 713.60 | 691.40 | 665.00 |
2,684.80
|
| ’21 | 510.70 | 631.90 | 636.70 | 635.60 |
2,414.90
|
| ’20 | 439.30 | 349.10 | 493.10 | 509.60 |
1,791.10
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (83.20) | 86.60 | — | — |
—
|
| ’25 | (83.80) | 44.60 | 33.00 | 146.20 |
140.00
|
| ’24 | (37.20) | 26.70 | 108.20 | 82.40 |
180.10
|
| ’23 | (97.80) | 143.70 | (38.90) | 114.80 |
121.80
|
| ’22 | (92.50) | (155.40) | (242.30) | 311.30 |
(178.90)
|
| ’21 | 26.30 | 25.40 | (34.70) | 69.80 |
86.80
|
| ’20 | (76.60) | 115.60 | 96.50 | 173.60 |
309.10
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (84.90) | 84.20 | — | — |
—
|
| ’25 | (91.40) | 41.20 | 30.10 | 145.60 |
125.50
|
| ’24 | (42.30) | 23.70 | 104.10 | 74.40 |
159.90
|
| ’23 | (105.10) | 218.70 | (43.20) | 118.70 |
107.20
|
| ’22 | (100.00) | (74.00) | (249.70) | 388.30 |
(125.40)
|
| ’21 | 24.10 | 20.90 | (38.00) | 62.20 |
69.20
|
| ’20 | (80.20) | 112.60 | 97.10 | 169.30 |
298.80
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.24 | 0.37 | — | — |
—
|
| ’25 | 0.13 | 0.32 | 0.30 | 0.38 |
1.14
|
| ’24 | (0.19) | 0.17 | 0.28 | 0.29 |
0.58
|
| ’23 | 0.23 | 0.30 | 0.11 | (1.15) |
(0.51)
|
| ’22 | 0.12 | 1.53 | 0.48 | (4.59) |
(2.37)
|
| ’21 | 0.45 | 0.53 | 0.00 | (0.18) |
0.81
|
| ’20 | 0.16 | (0.02) | 0.27 | (2.10) |
(1.70)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.60 | 7.21 | 7.58 | 9.58 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 29.75 | 17.85 | 24.64 | 32.80 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,300 | 4,100 | 3,100 | 3,050 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.62 | 0.55 | 0.57 | 0.61 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,684.80 | 2,242.90 | 1,755.00 | 1,874.30 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 39.87% | 38.96% | 44.33% | 47.31% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (252.90) | (132.80) | 58.10 | 121.50 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (9.42%) | (5.92%) | 3.31% | 6.48% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (189.10) | (38.10) | 48.80 | 101.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 34.60 | 35.10 | 26.20 | 25.90 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.69 | 28.14 | 21.94 | 23.08 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | (2.37) | (0.51) | 0.58 | 1.14 | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.24) | 1.53 | 2.25 | 1.72 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.67 | (0.18) | (0.25) | (0.18) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.57) | 1.35 | 2.00 | 1.55 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.25 | 3.76 | 4.03 | 5.21 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 79.70 | 79.70 | 80.00 | 81.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 0.00 | 0.00 | 40.36 | 16.06 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.33 | 0.31 | 1.01 | 0.79 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.64 | 2.30 | 5.51 | 3.48 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.56 | 0.50 | 1.25 | 0.97 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (42.23) | 3.05 | 5.22 | 4.71 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (178.90) | 121.80 | 180.10 | 140.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 53.50 | (14.60) | (20.20) | (14.50) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (125.40) | 107.20 | 159.90 | 125.50 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 155.00 | 155.70 | 162.60 | 208.30 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 733.00 | 615.80 | 578.00 | 546.70 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 601.50 | 436.80 | 425.90 | 340.40 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 339.00 | 300.00 | 322.10 | 423.10 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (7.41%) | (1.69%) | 2.42% | 5.66% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (13.85%) | (5.67%) | 8.15% | 12.30% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (38.30%) | (12.05%) | 14.53% | 25.71% | — | — | — |
ROE
|
Wolverine World Wide (WWW), home to brands like Merrell, Saucony, and Hush Puppies, has endured a rough decade of acquisition blunders, COVID shocks, and economic pressures, but its 2023 turnaround—featuring brand sales like Keds and debt refinancing—shows signs of stabilization in 2024. Revenue plunged 35% to $1.755 billion amid inventory issues and cost cuts, yet efficiency soared with gross margins jumping to 44.5% and revenue per employee holding steady around $550K-$625K despite a 47% headcount slash. Profitability flipped positive at $51.5 million net income, with FCF recovering to $2.00 per share, though volatile earnings and a shrunken balance sheet (equity down 68% to $317 million) keep risks high.
Debt lingers at $578 million (1.4x revenue), insider net selling raises flags despite some director buys, and valuation mixes cautionary signals: trailing P/E at 40x but forward dropping to 11x by 2027 on projected 6% annual revenue growth and EPS tripling to $1.66. The stock, down 75% from peaks, trades midway in its range with 30%+ upside to analyst targets if execution holds, but in a cutthroat consumer sector, consumer slowdowns and competition could derail it.
This risk-averse take highlights turnaround allure for patient investors—margin gains and FCF inflection point to potential—but urges waiting for 2025 proof before diving in, prioritizing downside protection over hype.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.